Access to anti-retroviral drugs, male in Canada
Canada: Access to anti-retroviral drugs, male was 78.0% in 2022. ▲ Rising
Access to anti-retroviral drugs, male in Canada, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
In 2022, access to anti-retroviral drugs, male in Canada stood at 78.0%.
That represents a change of down 1.3% on the previous year and up 56.0% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Canada peaked at 80.0% in 2020 and was at its lowest, 20.0%, in 2000.
That places Canada 51st out of 141 countries with data for 2022, putting it in the middle of the range.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, male in Canada, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 20.0% | — |
| 2001 | 23.0% | +15.0% |
| 2002 | 29.0% | +26.1% |
| 2003 | 30.0% | +3.4% |
| 2004 | 32.0% | +6.7% |
| 2005 | 33.0% | +3.1% |
| 2006 | 34.0% | +3.0% |
| 2007 | 36.0% | +5.9% |
| 2008 | 37.0% | +2.8% |
| 2009 | 46.0% | +24.3% |
| 2010 | 47.0% | +2.2% |
| 2011 | 48.0% | +2.1% |
| 2012 | 50.0% | +4.2% |
| 2013 | 63.0% | +26.0% |
| 2014 | 67.0% | +6.3% |
| 2015 | 70.0% | +4.5% |
| 2016 | 74.0% | +5.7% |
| 2017 | 74.0% | +0.0% |
| 2018 | 75.0% | +1.4% |
| 2019 | 77.0% | +2.7% |
| 2020 | 80.0% | +3.9% |
| 2021 | 79.0% | -1.2% |
| 2022 | 78.0% | -1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.0% | 20.0% | 46.0% | 10 |
| 2010s | 64.5% | 47.0% | 77.0% | 10 |
| 2020s | 79.0% | 78.0% | 80.0% | 3 |
Countries ranked near Canada
More gender data for Canada
- Child population (UN estimates and projections) 5,985 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.1285 % change on previous year (2030)
- Population 35,670 (2030)
- Working-age population (UN estimates and projections) 35,670 (2030)
- Population (UN estimates and projections), annual growth rate 0.8111 % change on previous year (2030)
- Age population, age 00, female, interpolated 179,464 (2025)
- Age population, age 00, male, interpolated 188,972 (2025)
- Age population, age 01, female, interpolated 181,929 (2025)
- Age population, age 01, male, interpolated 191,273 (2025)
- Age population, age 02, female, interpolated 183,113 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Canada?
- Access to anti-retroviral drugs, male in Canada was 78.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Canada?
- The highest recorded value was 80.0% in 2020.
- What is the lowest access to anti-retroviral drugs, male recorded in Canada?
- The lowest recorded value was 20.0% in 2000.
- How does Canada rank for access to anti-retroviral drugs, male?
- Canada ranks 51st out of 141 countries with data for 2022.
- Is access to anti-retroviral drugs, male rising or falling in Canada?
- Over the last ten years it is up 56.0%. The long-run trend across the full record is rising.
- Where does this Canada data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.